Gen Sobue

Okazaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 410 publications

Long-Term Tofersen in SOD1 Amyotrophic Lateral Sclerosis.

Long-Term Tofersen in SOD1 Amyotrophic Lateral Sclerosis.

Journal: JAMA neurology

Published: February 09, 2026

The TDP-43I383V heterozygous mutation results in increased TDP-43 expression and altered neuronal activity in ALS patient-derived iPSC motor neurons.

The TDP-43I383V heterozygous mutation results in increased TDP-43 expression and altered neuronal activity in ALS patient-derived iPSC motor neurons.

Journal: Neuroscience research

Published: October 08, 2025

Asthma-like bronchodilator responsiveness in patients with neuronal intranuclear inclusion disease.

Asthma-like bronchodilator responsiveness in patients with neuronal intranuclear inclusion disease.

Journal: Scientific reports

Published: September 02, 2025

Corrigendum to "Retinoic-acid-concentration-dependent acquisition of neural cell identity during in vitro differentiation of mouse embryonic stem cells" [Develop. Biol. 275 (2004) 124-42].

Corrigendum to "Retinoic-acid-concentration-dependent acquisition of neural cell identity during in vitro differentiation of mouse embryonic stem cells" [Develop. Biol. 275 (2004) 124-42].

Journal: Developmental biology

Published: August 23, 2025

Fatty acid amide hydrolase inhibition for treatment of amyotrophic lateral sclerosis.

Fatty acid amide hydrolase inhibition for treatment of amyotrophic lateral sclerosis.

Journal: JCI insight

Published: August 11, 2025

Pan-Asian consortium for treatment and research in ALS (PACTALS) guidelines for management of amyotrophic lateral sclerosis.

Pan-Asian consortium for treatment and research in ALS (PACTALS) guidelines for management of amyotrophic lateral sclerosis.

Journal: The Lancet regional health. Western Pacific

Published: June 01, 2025

Phase 3b Extension Study MT-1186-A04 to Evaluate the Continued Efficacy and Safety of Edaravone Oral Suspension for Up to an Additional 48 Weeks in Patients With Amyotrophic Lateral Sclerosis.

Phase 3b Extension Study MT-1186-A04 to Evaluate the Continued Efficacy and Safety of Edaravone Oral Suspension for Up to an Additional 48 Weeks in Patients With Amyotrophic Lateral Sclerosis.

Journal: Muscle & nerve

Published: May 02, 2025

Nation-wide Japanese FTD consortium FTLD-J: Utility of case review meetings.

Nation-wide Japanese FTD consortium FTLD-J: Utility of case review meetings.

Journal: International psychogeriatrics

Published: February 24, 2025

Erratum for Acute Unilateral Isolated Oculomotor Nerve Palsy in an Adult Patient with Influenza A.

Erratum for Acute Unilateral Isolated Oculomotor Nerve Palsy in an Adult Patient with Influenza A.

Journal: Internal medicine (Tokyo, Japan)

Published: November 04, 2024

Protocol for a phase 2 study of bosutinib for amyotrophic lateral sclerosis using real-world data: induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (iDReAM) study.

Protocol for a phase 2 study of bosutinib for amyotrophic lateral sclerosis using real-world data: induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (iDReAM) study.

Journal: BMJ open

Published: October 26, 2024

Efficacy and Safety of Once Daily Dosing vs. Approved On/Off Dosing of Edaravone Oral Suspension Up to 48 Weeks in Patients With Amyotrophic Lateral Sclerosis (Study MT-1186-A02).

Efficacy and Safety of Once Daily Dosing vs. Approved On/Off Dosing of Edaravone Oral Suspension Up to 48 Weeks in Patients With Amyotrophic Lateral Sclerosis (Study MT-1186-A02).

Journal: Muscle & nerve

Published: October 23, 2024

Safety Extension Study of Edaravone Oral Suspension in Patients With Amyotrophic Lateral Sclerosis for up to an Additional 96 Weeks of Treatment.

Safety Extension Study of Edaravone Oral Suspension in Patients With Amyotrophic Lateral Sclerosis for up to an Additional 96 Weeks of Treatment.

Journal: Muscle & nerve

Published: October 17, 2024

Showing 1-12 of 410

Last Updated: 09/26/2026